Submitted by Irena Rao on Fri, 21/03/2025 - 13:34
We are proud to announce that the Capsule Sponge testing team, led by Professor Rebecca Fitzgerald at the Early Cancer Institute, has won an NIHR Impact Prize.
The team has been recognised for their hard work and research to improve the detection and prevention of oesophageal cancer by using a swallowable 'sponge on a string.'
Professor Fitzgerald, director of the Early Cancer Institute, collected the award on behalf of the team at a ceremony in Birmingham on 20th March 2025.
Through the Impact Prizes, NIHR is celebrating researchers and teams who have had a major impact on the health and wealth of the nation, as well as globally.
The Capsule sponge testing team at the University of Cambridge developed a 'pill-on-a-string' device which can reliably detect the precursor to oesophageal cancer, Barrett's oesophagus. Used in clinics and GP surgeries, this device improves detection rates for people with Barrett’s oesophagus and in addition to earlier diagnosis, the device helps to save costs compared to traditional diagnosis. The judging panel said it was "a leading example of impactful innovation."
Watch the NIHR Impact Prize winner video about the Capsule Sponge:
This achievement highlights our commitment to research that makes a difference in health and care. Congratulations to all winners!
See the full list of winners: https://lnkd.in/et9UEdAg